334 related articles for article (PubMed ID: 30598522)
1. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study.
Jiménez-Lucena R; Camargo A; Alcalá-Diaz JF; Romero-Baldonado C; Luque RM; van Ommen B; Delgado-Lista J; Ordovás JM; Pérez-Martínez P; Rangel-Zúñiga OA; López-Miranda J
Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30598522
[TBL] [Abstract][Full Text] [Related]
2. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
[TBL] [Abstract][Full Text] [Related]
3. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
Roncero-Ramos I; Alcala-Diaz JF; Rangel-Zuñiga OA; Gomez-Delgado F; Jimenez-Lucena R; García-Rios A; Vals-Delgado C; Romero-Baldonado C; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
Clin Nutr; 2020 Feb; 39(2):492-500. PubMed ID: 30852029
[TBL] [Abstract][Full Text] [Related]
4. Circulating RNAs as predictive markers for the progression of type 2 diabetes.
Ghai V; Baxter D; Wu X; Kim TK; Kuusisto J; Laakso M; Connolly T; Li Y; Andrade-Gordon P; Wang K
J Cell Mol Med; 2019 Apr; 23(4):2753-2768. PubMed ID: 30734465
[TBL] [Abstract][Full Text] [Related]
5. Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study.
Seyhan AA; Nunez Lopez YO; Xie H; Yi F; Mathews C; Pasarica M; Pratley RE
Sci Rep; 2016 Aug; 6():31479. PubMed ID: 27558530
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus.
Weale CJ; Matshazi DM; Davids SFG; Raghubeer S; Erasmus RT; Kengne AP; Davison GM; Matsha TE
Diabetes Metab Syndr Obes; 2020; 13():5037-5047. PubMed ID: 33376373
[TBL] [Abstract][Full Text] [Related]
7. Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes.
Prabu P; Rome S; Sathishkumar C; Aravind S; Mahalingam B; Shanthirani CS; Gastebois C; Villard A; Mohan V; Balasubramanyam M
PLoS One; 2015; 10(5):e0128372. PubMed ID: 26020947
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
Nunez Lopez YO; Garufi G; Seyhan AA
Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-21 as a potential predictor in prediabetic individuals with a positive family history of type 2 diabetes mellitus.
Yazdanpanah Z; Kazemipour N; Kalantar SM; Vahidi Mehrjardi MY
Physiol Rep; 2022 Jan; 10(2):e15163. PubMed ID: 35076188
[TBL] [Abstract][Full Text] [Related]
10. Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.
Eyileten C; Wicik Z; Keshwani D; Aziz F; Aberer F; Pferschy PN; Tripolt NJ; Sourij C; Prietl B; Prüller F; von Lewinski D; De Rosa S; Siller-Matula JM; Postula M; Sourij H
Cardiovasc Diabetol; 2022 May; 21(1):79. PubMed ID: 35596173
[TBL] [Abstract][Full Text] [Related]
11. MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications.
Olivieri F; Spazzafumo L; Bonafè M; Recchioni R; Prattichizzo F; Marcheselli F; Micolucci L; Mensà E; Giuliani A; Santini G; Gobbi M; Lazzarini R; Boemi M; Testa R; Antonicelli R; Procopio AD; Bonfigli AR
Oncotarget; 2015 Nov; 6(34):35372-82. PubMed ID: 26498351
[TBL] [Abstract][Full Text] [Related]
12. Can miR-145-5p be used as a marker in diabetic patients?
Shahrokhi SZ; Saeidi L; Sadatamini M; Jafarzadeh M; Rahimipour A; Kazerouni F
Arch Physiol Biochem; 2022 Oct; 128(5):1175-1180. PubMed ID: 32412315
[TBL] [Abstract][Full Text] [Related]
13. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease.
Gallo W; Esguerra JLS; Eliasson L; Melander O
PLoS One; 2018; 13(11):e0206974. PubMed ID: 30408096
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.
Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G
Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403
[TBL] [Abstract][Full Text] [Related]
15. A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study.
Rangel-Zuñiga OA; Vals-Delgado C; Alcala-Diaz JF; Quintana-Navarro GM; Krylova Y; Leon-Acuña A; Luque RM; Gomez-Delgado F; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
Mol Ther Nucleic Acids; 2021 Mar; 23():255-263. PubMed ID: 33425484
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches.
Ghoreishi E; Shahrokhi SZ; Kazerouni F; Rahimipour A
BMC Endocr Disord; 2022 Aug; 22(1):207. PubMed ID: 35978298
[TBL] [Abstract][Full Text] [Related]
17. Mediterranean diet improves endothelial function in patients with diabetes and prediabetes: A report from the CORDIOPREV study.
Torres-Peña JD; Garcia-Rios A; Delgado-Casado N; Gomez-Luna P; Alcala-Diaz JF; Yubero-Serrano EM; Gomez-Delgado F; Leon-Acuña A; Lopez-Moreno J; Camargo A; Tinahones FJ; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Lopez-Miranda J
Atherosclerosis; 2018 Feb; 269():50-56. PubMed ID: 29274507
[TBL] [Abstract][Full Text] [Related]
18. Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study.
Jiménez-Lucena R; Rangel-Zúñiga OA; Alcalá-Díaz JF; López-Moreno J; Roncero-Ramos I; Molina-Abril H; Yubero-Serrano EM; Caballero-Villarraso J; Delgado-Lista J; Castaño JP; Ordovás JM; Pérez-Martinez P; Camargo A; López-Miranda J
Mol Ther Nucleic Acids; 2018 Sep; 12():146-157. PubMed ID: 30195754
[TBL] [Abstract][Full Text] [Related]
19. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus.
Liu Y; Gao G; Yang C; Zhou K; Shen B; Liang H; Jiang X
Int J Mol Sci; 2014 Jun; 15(6):10567-77. PubMed ID: 24927146
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals.
Zhang T; Li L; Shang Q; Lv C; Wang C; Su B
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):60-3. PubMed ID: 25986735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
